Press Releases Theralase’s Phase Ib Non-Muscle Invasive Bladder Cancer Clinical Study Research Presented at the American Urological AssociationMay 06, 2019Theralase® Commences Phase II NMIBC Clinical StudyApril 25, 2019Theralase’s Latest Scientific Research to be Presented at the 17th Annual International Photodynamic Association World CongressApril 22, 2019Theralase® Releases 2018 Year End Audited Financial StatementsApril 17, 2019Patient Six Cancer-Free Twelve Months After Single Anti-Cancer TreatmentApril 02, 2019Theralase’s Phase IB Clinical Study to be Presented at the 17th International Photodynamic Association World CongressMarch 26, 2019Theralase® Granted United States Patent to Destroy Cancer Cells with X-Ray Activated Photo Dynamic CompoundsMarch 04, 2019Theralase® Achieves Third Place in the Clean Technology and Life Sciences Category on the 2019 TSX Venture 50February 28, 2019Theralase® Announces Appointment of New Chief Executive OfficersFebruary 25, 2019Theralase® Patient Five Cancer-Free Twelve Months After Single Anti-Cancer TreatmentJanuary 31, 2019Theralase® Patient Six Cancer-Free at Nine Months After Single Anti-Cancer TreatmentJanuary 30, 2019Theralase® Completes $1.4 M Private Placement Equity FinancingJanuary 09, 2019Health Canada Grants ITA Approval to Commence Phase II Clinical StudyDecember 10, 2018Theralase’s Rutherrin® Photo Dynamic Therapy Induces Immune Response to Destroy Human Brain Cancer CellsNovember 30, 2018Theralase® Release 3Q2018 Financial StatementsNovember 29, 2018Theralase® Granted Canadian Anti-Cancer PatentNovember 15, 2018Patient Five Cancer-Free After Single PDT TreatmentNovember 08, 2018Theralase® Anti-Cancer Technology Shows Promise for Esophageal Cancer Using Targeted Molecular Delivery SystemOctober 09, 2018Theralase® Announces Completion of Non-Brokered Private Placement for Approximately $1.1 millionOctober 03, 2018Health Canada Approves Commencement of Phase II Clinical StudySeptember 10, 2018« Previous12345…11Next » We exhibit at .. Discover our Therapeutic Lasers Read our latest blog articles .. Developing a Potential Cure for Bladder Cancer Theralase – Participating in Bladder Cancer Walk 2019 Canadian Clinical Stage Biopharmaceutical Company Advances New Cancer Treatment Active Rehabilitation – How Much is Too Much? Speeding up Athletes’ Recovery ✴ Guest blog post by Dr. JEFFREY TUCKER, D.C. Theralase Laser Technology – The Magic Lamp? ✴ Guest blog post by Dr. JAMES W. GREGG, D.C. Treating Sports-Related Ankle Sprains Natural, Drug-free Pain Management ✴ Guest blog post by Dr. JEFFREY TUCKER, D.C. Are Soccer Moms Now the Candidates Most Likely to Succumb to Drug Addiction? Everything You Need To Know About Class 3 vs. Class 4 123
